Cancer drug spending surges to $100B in 2014
Global annual spending on cancer drugs in 2014 hit $100B (+10% Y/Y) for the first time, largely due to rising drug prices and increased incidence of cancer.
"Earlier diagnosis, longer treatment duration and increased effectiveness of drug therapies are contributing to rising levels of spending on medicines for cancer," the IMS said in a report.
The figures raise even more questions of affordability as the pharmaceuticals industry prepares to launch a fresh generation of treatments that promise to push costs even higher.
invest at your own risk, based on your own due diligence, at your own risk tolerance